GLP-1s and Muscle Mass: What Clinicians Recommend for Body Composition

One of the most discussed concerns about GLP-1 medications is muscle loss. When you lose weight — through any mechanism — some of that weight comes from lean body mass, including muscle. The critical clinical question isn't whether muscle loss occurs (it does), but how much, whether it's clinically meaningful, and what evidence-based strategies minimize it.

What the Clinical Trial Data Shows

In the STEP 1 trial (semaglutide 2.4 mg), body composition analysis using DEXA scans showed that approximately 39% of total weight lost was lean body mass, with the remaining 61% being fat mass. In the SURMOUNT-1 trial (tirzepatide), the lean mass proportion was similar at approximately 25-33% depending on the dose level.

To put this in perspective, this ratio is consistent with weight loss from other interventions including caloric restriction, bariatric surgery, and other weight loss medications. It is not uniquely attributable to GLP-1 pharmacology. Any caloric deficit produces lean mass loss alongside fat loss because the body draws on both energy reserves.

The clinical significance of this lean mass loss depends on context. For a patient losing 40 pounds, losing 15 pounds of lean mass and 25 pounds of fat represents a meaningful change in body composition. For an older patient with already-compromised muscle mass, this loss could cross a threshold into sarcopenic obesity — a condition where low muscle mass coexists with excess fat and increases fall risk, metabolic dysfunction, and functional impairment.

Protein: The Foundation of Muscle Preservation

Adequate protein intake is the single most important dietary factor for preserving lean mass during GLP-1-mediated weight loss. Current clinical recommendations for GLP-1 patients are more aggressive than general population guidelines:

Target: 0.7-1.0 grams of protein per pound of ideal body weight daily. For a patient with an ideal body weight of 160 pounds, this means 112-160 grams of protein per day.

This target is challenging for GLP-1 patients because appetite suppression makes eating feel effortful, and protein-rich foods are particularly satiating. Practical strategies include:

• Prioritize protein at every meal — eat the protein portion first, before vegetables or carbohydrates, when appetite is strongest
• Protein supplementation — whey protein isolate, casein, or plant-based protein powders can help bridge the gap when whole food intake is insufficient. A protein shake between meals is often better tolerated than trying to eat larger meals.
• High-protein snack strategy — Greek yogurt, cottage cheese, jerky, protein bars, hard-boiled eggs as between-meal protein sources
• Track protein intake — even loosely, for the first few months until high-protein eating patterns become habitual

Resistance Training: The Evidence-Based Intervention

Exercise during GLP-1 treatment has two distinct roles: cardiovascular exercise supports overall metabolic health, while resistance training specifically targets lean mass preservation. Both matter, but for the muscle mass question, resistance training is the priority.

The STEP 1 sub-study that included exercise counseling showed that patients who engaged in regular physical activity — and particularly resistance training — lost a higher proportion of fat relative to lean mass compared to those who were sedentary. This finding is consistent with decades of body composition research across weight loss modalities.

Minimum effective dose: Two to three resistance training sessions per week, targeting all major muscle groups, with progressive overload (gradually increasing weight or volume over time). This doesn't require a gym membership — bodyweight exercises, resistance bands, and home dumbbells are sufficient for most patients starting out.

Starting point for beginners: If you've never done resistance training, start with guided programs. Many telehealth GLP-1 providers now include exercise coaching or can refer to qualified personal trainers familiar with weight loss medication patients.

Monitoring Body Composition

The bathroom scale doesn't tell you what kind of weight you're losing. More informative measures include:

• DEXA scan — the gold standard for body composition analysis, providing precise measurements of fat mass, lean mass, and bone density. Available at many imaging centers for $50-150.
• Bioelectrical impedance analysis (BIA) — available in many smart scales and clinical settings. Less precise than DEXA but useful for tracking trends over time.
• Waist circumference — a simple but meaningful measure. Decreasing waist circumference indicates visceral fat loss, which is the most metabolically beneficial component of weight loss.
• Functional strength assessments — can you carry groceries, climb stairs, get up from a chair without using your arms? Maintaining functional strength is more clinically meaningful than abstract muscle mass numbers for most patients.